EU-funded Parkinson’s research project launched at University of Luxembourg

News

Author: Almaz OhenePublished: 9 December 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The EU is funding a €5.9 million research project at the University of Luxembourg that aims to develop new techniques to identify active compounds for use in the treatment of Parkinson’s disease.

Researchers will concentrate on patterns of Parkinson’s disease in which the mitochondria – the part of the cell that takes in nutrients – are damaged by mutations in individual genes.

The project, Systems Medicine of Mitochondrial Parkinson’s Disease (SysMedPD), brings together partner institutions and pharmaceutical companies from across Europe such as Luxembourg, Germany, Ireland, the Netherlands and the UK.

Dr Ronan Fleming, LCSB scientist and SysMedPD coordinator, said: “We estimate that in about 10-20% of all Parkinson’s patients, their mitochondria do not function properly. In order to better diagnose, heal or at least effectively curb the progression of Parkinson’s disease, we must understand this dysfunction of mitochondria in detail.”

Go Back

Share this story

Comments


Related articles


Tour de Fox 2016 series

Global update

Michael J Fox Foundation Tour de Fox Series 2016

Registration for the Team Fox summer 2016 cycle series now open

READ MORE
croatia-unity-walk

Europe

IN PICTURES: Croatian Unity Walk triumphs over Parkinson’s

Croatia Parkinson’s organisation holds fourth Unity Walk

READ MORE
Sabine smiles for a photo.

sponsored article

PD in Practice

“Telemedicine has the potential to take a great deal of burden off patients and families”

A neurologist and a person with Parkinson’s disease talk remote care

READ MORE